Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals.

Adil AL-Nahhas

Journal: Nuclear medicine communications 2005;25(9):891-5

PMID: 15319593

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Department of Nuclear Medicine, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. [email protected]

DOI: 10.1097/00006231-200409000-00005

Link outs

Free resources

Medical:

https://medlineplus.gov/thyroidcancer.html

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://doi.org/10.1097/00006231-200409000-00005

MeSH Terms: Clinical Trials as Topic, Fluorodeoxyglucose F18, Humans, Iodine Radioisotopes, Positron-Emission Tomography, Prognosis, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Technetium Compounds, Thallium, Thyroid Neoplasms

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.